Airway diseases
Thematic poster
Clinical and functional monitoring in airway disease
Methods :
Cell and molecular biology, General respiratory patient care, Epidemiology, Physiology
Chairs
P. Kirkham
Wolverhampton (West Midlands)
(United Kingdom)
Late Breaking Abstract - Effect on asthma control using a novel digital self-management system: a physician blinded randomised controlled cross-over pilot trial
B. Nordlund(Bromma, Sweden)
COI
1
Asthma control: how does patient perception relate to ACT and CARAT scores?
T. Guerreiro(Moita, Portugal)
COI
2
Association of Asthma Control Test (ACT) and Asthma Control Questionnaire (ACQ) with asthma exacerbation
M. Uematsu(Fukushima, Japan)
COI
3
Assessment of the broncodilator response using different methods: impulse oscilometry vs spirometry.
I. Salinas Garrido(VIZCAYA, Spain)
COI
4
Tachyphylaxis and cough reflex sensitivity
N. James(Cottingham, United Kingdom)
COI
5
Methacholine challenge test with impulse oscillometry versus spirometry: which is more sensitive in detecting airway hyper-responsiveness (AHR?)
A. Sharifi(Tabriz, Islamic Republic of Iran)
COI
6
Investigation of shortened lung clearance index (LCI) in the Bronch-UK Clinimetrics study.
K. O'Neill(Belfast (Belfast), United Kingdom)
COI
7
Small airway impairment in severe asthmatic patients
L. Morandi(Ferrara (FE), Italy)
COI
8
Exhaled breath profiling by electronic nose enabled discrimination of allergic rhinitis and extrinsic asthma.
S. Dragonieri(Bari (BA), Italy)
COI
9
Electronic monitoring devices: the saviour of poor control in asthma?
I. Adejumo(Nottingham (Nottinghamshire), United Kingdom)
COI
10
Small airways disease evaluation in patients with mild/moderate asthma and correlation with bronchial hyperresponsiveness and disease control
M. Kipourou(Thermi Thessaloniki, Greece)
COI
11
A correlative analysis between spirometry and MostGraph using the 23306 data from 3979 patients in clinical practice.
Y. Nakamura(Matsusaka City, Mie Prefecture, Japan)
COI
12
Airway hyperresponsiveness to mannitol is an independent marker of asthma control and disease phenotype
A. Sverrild(Valby, Denmark)
COI
13
Usefulness of mannitol challenge testing for diagnosing asthma in everyday clinical practice
C. Suppli Ulrik(Virum, Denmark)
COI
14
Earlier use of fractional exhaled Nitric Oxide (FeNO) and challenge testing improves speed and accuracy of asthma diagnosis. MacLeod J, Respiratory Physiology, Bradshaw TA, Respiratory Medicine, Royal Infirmary of Edinburgh
J. MacLeod(Edinburgh (Edinburgh), United Kingdom)
COI
15
Multiple Breath Washout (MBW) training, certification and quality control during the iBEST-1 trial in bronchiectasis (BE).
K. O'Neill(Belfast (Belfast), United Kingdom)
COI
16
A novel point of care test for sputum sample stratification prior to the quantitative measurement of active neutrophil elastase
D. McCafferty(Belfast (Belfast), United Kingdom)
COI
17
Repeatabillity of PExA SPA and albumin as small airways dysfunction candidate biomarkers in Asthma.
M. Soares(Leicester (Leicestershire), United Kingdom)
COI
18
Evaluating the accuracy of commercially available finger pulse oximeters in a hospital setting
19
Fractional exhaled nitric oxide (FeNO) suppression with directly observed inhaled corticosteroid therapy: does it make a difference to patient outcomes?
S. Faruqi(Cottingham, United Kingdom)
COI
20
. . .
